Paper19252334
Mechanistic basis of using body size and maturation to predict clearance in humans.
Anderson BJ and 1 other. Drug Metab Pharmacokinet, 2009. Cited by 431 papers, by iCite.
Cite this record
ConductScience Library. Mechanistic basis of using body size and maturation to predict clearance in humans. Papers, record 19252334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19252334
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aging | Major topic |
| Body Size | Major topic |
| Pharmaceutical Preparations | Major topic |
| Acetaminophen | |
| Animals | |
| Body Surface Area | |
| Glomerular Filtration Rate | |
| Humans | |
| Kidney | |
| Liver | |
| Metabolic Detoxication, Phase I | |
| Metabolic Detoxication, Phase II | |
| Models, Biological | |
| Morphine | |
| Predictive Value of Tests |
Source PubMed
Cited by279
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 431 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42814651 | Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35). | JMIR Res Protoc | 2026 | https://conductscience.org/library/papers/42814651 | PubMed |
| 42678337 | Dose Selection for Ceftibuten Combined with Avibactam Tomilopil, a Potential Oral Alternative to Carbapenems for Patients with Complicated Urinary Tract Infections. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42678337 | PubMed |
| 42627441 | Model-Informed Precision Dosing in Pediatric Patients: Current Software Tools and Bedside Guided Application. | Paediatr Drugs | 2026 | https://conductscience.org/library/papers/42627441 | PubMed |
| 42515770 | Advancing Pediatric Dose Scaling: Strategies, Modeling Approaches, and Clinical Applications. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515770 | PubMed |
| 42515693 | Population Pharmacokinetic Analysis and Modelling of Serum Uric Acid Dynamics in Patients Treated with Favipiravir. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515693 | PubMed |
| 42509527 | Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/42509527 | PubMed |
| 42471329 | A dynamic pharmacometric framework defining the relationship between ivermectin exposure and mosquito lethality. | Sci Rep | 2026 | https://conductscience.org/library/papers/42471329 | PubMed |
| 42387116 | Impact of Febrile State on Vancomycin Clearance in Pediatric Patients: Insights From Population Pharmacokinetic Modeling. | Pharm Res | 2026 | https://conductscience.org/library/papers/42387116 | PubMed |
| 42385200 | Impact of cumulative glucocorticoid exposure on vancomycin clearance in hospitalized children: A retrospective cohort study. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42385200 | PubMed |
| 42377866 | Population Pharmacokinetic Modelling of Dolutegravir: A Narrative Review. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/42377866 | PubMed |
| 42244880 | Developmental age and clinical illness drive in vivo variability of CYP1A2 ontogeny and caffeine metabolism in preterm neonates. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42244880 | PubMed |
| 42198273 | Pharmacokinetics of Monoclonal Antibodies in Pediatrics: Model-Based Investigation on Allometric Scaling Exponents. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42198273 | PubMed |
| 41983018 | Albumin and Other Plasma Proteins in Pediatric Patients: What, When, and How Much They Influence Antimicrobial Pharmacology. | J Pediatr Pharmacol Ther | 2026 | https://conductscience.org/library/papers/41983018 | PubMed |
| 41869741 | Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir-ritonavir in patients with COVID-19. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41869741 | PubMed |
| 41665863 | Single Saliva Sample Model-Informed Precision Dosing of Levofloxacin for Multidrug-Resistant Tuberculosis. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/41665863 | PubMed |
| 41536035 | Population pharmacokinetics and dose-response relationships of mitoxantrone in children with acute myeloid leukaemia. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41536035 | PubMed |
| 41499525 | PET/CT imaging of tuberculosis lung lesions in marmosets treated with different drug regimens aligns with human clinical outcomes. | Sci Transl Med | 2026 | https://conductscience.org/library/papers/41499525 | PubMed |
| 41471106 | Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41471106 | PubMed |
| 41348398 | Pharmacokinetics and Target Attainment of Fluoroquinolones in Older Adults: A Systematic Review. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/41348398 | PubMed |
| 41313259 | Development of population pharmacokinetic models of total and free piperacillin in critically ill children and young adults for Monte Carlo simulations and model-informed precision dosing. | J Antimicrob Chemother | 2026 | https://conductscience.org/library/papers/41313259 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19252334
GET https://conductscience.org/api/papers/v1/19252334/cited_by?page=2